Skip to main content
REMEVi

Epitalon cost: prescription vs research grade

Published third-party prices by category, dated and sourced. REMEVi does not currently price Epitalon.

Published prices for Epitalon vary widely: telehealth programs list monthly or per-course prices, research-grade vials list for less, and we found no published clinic price. Most figures predate HHS’s October 2026 policy. Epitalon is not FDA-approved, REMEVi does not currently offer it, and REMEVi does not currently price Epitalon.

Epitalon is not FDA-approved. Since HHS’s October 2026 interim policy, a state-licensed 503A pharmacy may compound it on a patient-specific prescription under listed conditions.

REMEVi does not currently offer Epitalon.

What Epitalon costs by channel

Published prices, checked 2026-11-02. Sources linked.
CategoryPublished figureWhat the figure coversPublished
Telehealth peptide programs (individual listings)$320 per 10-day course to $449 per monthThree programs with a listed price; most listed programs gave no priceProvider comparison page, read 2026-11-02
Clinic programsNo published price found (checked 2026-11-02)——
Research-grade vialsNo published price cited (checked 2026-11-02)Figures appear on seller pages for research-use vials, which this page does not cite—

These figures were published before HHS’s October 30, 2026 policy, and listings may change as pharmacies apply it. A price quoted to you should state what it includes: the evaluation, the prescription, the product, supplies and follow-up.

What the CoA and registered-source requirements add

Under the policy, a covered Epitalon product starts from bulk substance made at an FDA-registered, CGMP-compliant facility and shipped with a valid certificate of analysis, the document that states the identity and purity testing for that lot. A state-licensed 503A pharmacy then prepares it for one named patient, labels it and reports serious adverse events to MedWatch. Each of those steps carries cost.

Why “research grade” is cheaper and what it lacks

  • No prescription, no licensed provider and no pharmacy dispensing.
  • No requirement for a registered bulk source or a certificate of analysis for the lot you receive.
  • Not prepared or labelled for human use, and outside the HHS policy.
  • No MedWatch reporting obligation if something goes wrong.

On August 24, 2026, FDA sent warning letters to five online peptide vendors whose “research use” labels did not outweigh evidence the products were sold for people.

Does REMEVi sell Epitalon?

No. REMEVi does not currently offer Epitalon and does not currently price Epitalon. REMEVi’s prescriptions today are NAD+, sermorelin and GLP-1 treatment.

How much does Epitalon cost?

Published third-party prices vary by channel. Telehealth programs list monthly or per-course figures, research-grade vials list for less, and we found no published clinic price on November 2, 2026. Most figures predate the October 2026 HHS policy. The table above lists each figure with its date and source.

Sources

  1. Telehealth Ally — Epithalon: evidence, FDA status & telehealth providers (2026) (read November 2, 2026)
  2. HHS — Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, 91 FR 68526 (Federal Register, October 30, 2026) (read November 2, 2026)
  3. Foley & Lardner, National Law Review 2026 — Peptides: HHS announces limited enforcement discretion for compounding six peptides (read November 2, 2026)
  4. Holland & Knight 2026 — Peptides at a crossroads: what wellness providers need to know (read November 2, 2026)

Medically reviewed by Linda West-Conforti, RN · CA RN #389453 ·